Quality of life of patients with acute coronary syndrome and peripheral artery disease in cardiovascular rehabilitation

Authors

Abstract

Introduction: The coexistence of peripheral artery disease in patients with acute coronary syndrome affects health-related quality of life. Cardiac rehabilitation is an effective tool for the treatment of both diseases.

Objective: To assess health-related quality of life according to the EQ-5D questionnaire before and after rehabilitation.

Method: A total of 484 patients discharged from the coronary care unit with a diagnosis of acute coronary syndrome were studied. They were diagnosed with peripheral artery disease by ankle-brachial index test and started cardiac rehabilitation from March the 1st, 2011 to February the 30th, 2018. Their quality of life was assessed using the EQ-5D questionnaire before and after rehabilitation. The Pearson correlation coefficient was employed for quantitative variables and the Wilcoxon nonparametric test was utilized to contrast the hypothesis of equality between two population medians in ordinal and interval variables.

Results: The dimensions assessed by the EQ-5D quality of life questionnaire show a positive correlation between pain-free walking distance and exercise time with the results of the EQ-5D score, thus demonstrating the benefits of rehabilitation.

Conclusions: Cardiac rehabilitation improved the quality of life of patients with peripheral artery disease and acute coronary syndrome.

Downloads

Download data is not yet available.

References

1. Jansen SCP, Hoorweg BBN, Hoeks SE, van den Houten MML, Scheltinga MRM, Teijink JAW, et al. A systematic review and meta-analysis of the effects of supervised exercise therapy on modifiable cardiovascular risk factors in intermittent claudication. J Vasc Surg. 2019;69(4):1293-308.e2. DOI: https://doi.org/10.1016/j.jvs.2018.10.069

2. Kalinin RE, Suchkov IA, Mzhavanadze ND, Pshennikov AS, Ncheĭe AF. Current aspects of performing treadmill test in patients with peripheral artery disease. Angiol Sosud Khir. 2019;25(2):25-33. DOI: https://doi.org/10.33529/angio2019209

3. Pereira RJ, Cotta RMM, Franceschini SdCC, Ribeiro RdCL, Sampaio RF, Priore SE, et al. Contribuição dos domínios físico, social, psicológico e ambiental para a qualidade de vida global de idosos. Rev Psiquiatr Rio Gd Sul. 2006;28(1):27-38. DOI: https://doi.org/10.1590/S0101-81082006000100005

4. Gardner AW, Waldstein SR, Montgomery PS, Zhao YD. Effect of cognitive status on exercise performance and quality of life in patients with symptomatic peripheral artery disease. J Vasc Surg. 2016;63(1):98-104. DOI: https://doi.org/10.1016/j.jvs.2015.08.064

5. Novakovic M, Jug B, Lenasi H. Clinical impact of exercise in patients with peripheral arterial disease. Vascular. 2017;25(4):412-22. DOI: https://doi.org/10.1177/1708538116678752

6. Badia X, Roset M, Montserrat S, Herdman M, Segura A. La versión española del EuroQol: descripción y aplicaciones. Med Clin (Barc). 1999;112(Supl 1):79-85.

7. Ibanez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H, et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2018;39(2):119-77. DOI: https://doi.org/10.1093/eurheartj/ehx393

8. Arós F, Boraita A, Alegría E, Alonso AM, Bardají A, Lamiel R, et al. Guías de práctica clínica de la Sociedad Española de Cardiología en pruebas de esfuerzo. Rev Esp Cardiol. 2000;53(8):1063-94.

9. Ades PA. Cardiac rehabilitation and secondary prevention of coronary heart disease. N Engl J Med. 2001;345(12):892-902. DOI: https://doi.org/10.1056/nejmra001529

10. Anderson JL, Halperin JL, Albert NM, Bozkurt B, Brindis RG, Curtis LH, et al. Management of patients with peripheral artery disease (compilation of 2005 and 2011 ACCF/AHA guideline recommendations): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2013;127(13):1425-43. DOI: http://dx.doi.org/10.1161/CIR.0b013e31828b82aa

11. Aboyans V, Ricco J-B, Bartelink M-LE, Björck M, Brodmann M, Cohnert T, et al. Guía ESC 2017 sobre el diagnóstico y tratamiento de la enfermedad arterial periférica, desarrollada en colaboración con la European Society for Vascular Surgery (ESVS). Rev Esp Cardiol. 2018;71(2):111.e1-69. DOI: https://dx.doi.org/10.1016/j.recesp.2017.11.035

12. Vaidya A, Kleinegris MC, Severens JL, Ramaekers BL, Ten Cate-Hoek AJ, Ten Cate H, Joore MA. Comparison of EQ-5D and SF-36 in untreated patients with symptoms of intermittent claudication. J Comp Eff Res. 2018 Jun;7(6):535-548. DOI: https://doi.org/10.2217/cer-2017-0029

13. Schweikert B, Hunger M, Meisinger C, König HH, Gapp O, Holle R. Quality of life several years after myocardial infarction: comparing the MONICA/KORA registry to the general population. Eur Heart J. 2009;30(4):436-43. DOI: https://doi.org/10.1093/eurheartj/ehn509

14. Forte EH, Pedroza CE, Graziano FI, Lagos C, Iglesias R. Calidad de vida de los pacientes con infarto de miocardio. Rev Fed Arg Cardiol. 2018;47(4):196-200.

15. Herdmana M, Badiab X, Berra S. El EuroQol-5D: una alternativa sencilla para la medición de la calidad de vida relacionada con la salud en atención primaria. Aten Primaria. 2001;28(6):425-9. DOI: https://doi.org/10.1016/S0212-6567(01)70406-4

16. World Medical Association. Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013;310(20):2191-4. DOI: https://doi.org/10.1001/jama.2013.281053

17. Bhatt DL, Steg PG, Ohman EM, Hirsch AT, Ikeda Y, Mas JL, et al. International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis. JAMA. 2006;295(2):180-9. DOI: https://doi.org/10.1001/jama.295.2.180

18. Criqui MH, Aboyans V. Epidemiology of peripheral artery disease. Circ Res. 2015;116(9):1509-26. DOI: https://doi.org/10.1161/circresaha.116.303849

19. Quiles J, Morillas P, Bertomeu V, Mazon P, Cordero A, Soria F, et al. Combination of ankle brachial index and diabetes mellitus to predict cardiovascular events and mortality after an acute coronary syndrome. Int J Cardiol. 2011;151(1):84-8. DOI: https://doi.org/10.1016/j.ijcard.2010.04.097

20. Bowlin SJ, Medalie JH, Flocke SA, Zyzanski SJ, Goldbourt U. Epidemiology of intermittent claudication in middle-aged men. Am J Epidemiol. 1994;140(5):418-30. DOI: https://doi.org/10.1093/oxfordjournals.aje.a117264

21. Kannel WB, McGee DL. Update on some epidemiologic features of intermittent claudication: the Framingham Study. J Am Geriatr Soc. 1985;33(1):13-8. DOI: https://doi.org/10.1111/j.1532-5415.1985.tb02853.x

22. Cauley JA, Kassem AM, Lane NE, Thorson S. Prevalent peripheral arterial disease and inflammatory burden. BMC Geriatr [Internet]. 2016 [citado 20 Mar 2020];16(1):213. Disponible en: https://doi.org/10.1186/s12877-016-0389-9

23. Criqui MH, Fronek A, Barrett-Connor E, Klauber MR, Gabriel S, Goodman D. The prevalence of peripheral arterial disease in a defined population. Circulation. 1985;71(3):510-5. DOI: https://doi.org/10.1161/01.cir.71.3.510

24. Hooi JD, Kester AD, Stoffers HE, Overdijk MM, van Ree JW, Knottnerus JA. Incidence of and risk factors for asymptomatic peripheral arterial occlusive disease: a longitudinal study. Am J Epidemiol. 2001;153(7):666-72. DOI: https://doi.org/10.1093/aje/153.7.666

25. Murabito JM, Evans JC, Nieto K, Larson MG, Levy D, Wilson PW. Prevalence and clinical correlates of peripheral arterial disease in the Framingham Offspring Study. Am Heart J. 2002;143(6):961-5. DOI: https://doi.org/10.1067/mhj.2002.122871

26. de Oliveira DC, Correia A, Nascimento Neto J, Gurgel M, Sarinho FW, Victor EG. Association Between Ankle-Brachial Index and Coronary Lesions Assessed by Coronary Angiography. Cardiol Res. 2015;6(1):216-20. DOI: https://doi.org/10.14740/cr376w

27. Flaherty JD, Bax JJ, De Luca L, Rossi JS, Davidson CJ, Filippatos G, et al. Acute heart failure syndromes in patients with coronary artery disease early assessment and treatment. J Am Coll Cardiol. 2009;53(3):254-63. DOI: https://doi.org/10.1016/j.jacc.2008.08.072

28. Ward RP, Goonewardena SN, Lammertin G, Lang RM. Comparison of the frequency of abnormal cardiac findings by echocardiography in patients with and without peripheral arterial disease. Am J Cardiol. 2007;99(4):499-503. DOI: https://doi.org/10.1016/j.amjcard.2006.09.102

29. Gardner AW, Parker DE, Montgomery PS, Blevins SM. Step-monitored home exercise improves ambulation, vascular function, and inflammation in symptomatic patients with peripheral artery disease: a randomized controlled trial. J Am Heart Assoc [Internet]. 2014 [citado 24 Mar 2020];3(5):e001107. Disponible en: https://doi.org/10.1161/jaha.114.001107

30. Thatipelli MR, Pellikka PA, McBane RD, Rooke TW, Rosales GA, Hodge D, et al. Prognostic value of ankle-brachial index and dobutamine stress echocardiography for cardiovascular morbidity and all-cause mortality in patients with peripheral arterial disease. J Vasc Surg. 2007;46(1):62-70. DOI: https://doi.org/10.1016/j.jvs.2007.03.022

31. Arrarás JI. La calidad de vida en el paciente oncológico [Internet]. Repositorio institucional UNED Pamplona [citado 24 Mar 2020]. Disponible en: https://www.bit.ly/2wRwvdC

32. Wu AW, Jacobson DL, Berzon RA, Revicki DA, van der Horst C, Fichtenbaum CJ, et al. The effect of mode of administration on medical outcomes study health ratings and EuroQol scores in AIDS. Qual Life Res. 1997;6(1):3-10. DOI: https://doi.org/10.1023/a:1026471020698

33. Bosch JL, Hunink MG. Comparison of the Health Utilities Index Mark 3 (HUI3) and the EuroQol EQ-5D in patients treated for intermittent claudication. Qual Life Res. 2000;9(6):591-601. DOI: https://doi.org/10.1023/A:1008929129537

34. The World Health Organization. Quality of Life assessment (WHOQOL): Position paper from the World Health Organization. Soc Sci Med. 1995;41(10):1403-9. DOI: https://dx.doi.org/10.1016/0277-9536(95)00112-K

35. Ellis JJ, Eagle KA, Kline-Rogers EM, Erickson SR. Validation of the EQ-5D in patients with a history of acute coronary syndrome. Curr Med Res Opin. 2005;21(8):1209-16. DOI: https://doi.org/10.1185/030079905x56349

36. Aragao JA, Santos RM, Neves OMG, Aragao ICS, Aragao FMS, Mota MIA, et al. Quality of life in patients with peripheral artery disease. J Vasc Bras. 2018;17(2):117-21. DOI: https://dx.doi:doi.org/10.1590/1677-5449.009017

37. Parmenter BJ, Dieberg G, Phipps G, Smart NA. Exercise training for health-related quality of life in peripheral artery disease: a systematic review and meta-analysis. Vasc Med. 2015;20(1):30-40. DOI: https://doi.org/10.1177/1358863x14559092

38. Saratzis A, Paraskevopoulos I, Patel S, Donati T, Biasi L, Diamantopoulos A, et al. Supervised Exercise Therapy and Revascularization for Intermittent Claudication: Network Meta-Analysis of Randomized Controlled Trials. JACC Cardiovasc Interv. 2019;12(12):1125-36. DOI: https://doi.org/10.1016/j.jcin.2019.02.018

39. Mazari FA, Carradice D, Rahman MN, Khan JA, Mockford K, Mehta T, et al. An analysis of relationship between quality of life indices and clinical improvement following intervention in patients with intermittent claudication due to femoropopliteal disease. J Vasc Surg. 2010;52(1):77-84. DOI: https://dx.doi.org/10.1016/j.jvs.2010.01.085

Downloads

Published

2021-04-18

How to Cite

1.
Negrín Valdés T, Rodríguez Jiménez AE, Fardales Rodríguez R, Castellano Gallo LA, Meneses Jiménez JC, Rabassa López-Callejas MA. Quality of life of patients with acute coronary syndrome and peripheral artery disease in cardiovascular rehabilitation. CorSalud [Internet]. 2021 Apr. 18 [cited 2025 Sep. 11];13(2):155-6. Available from: https://revcorsalud.sld.cu/index.php/cors/article/view/756

Issue

Vol. 13 No. 2 (2021)

Section

ORIGINAL ARTICLES

License

Authors who publish with this journal agree to the following terms:

    1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
    2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.